Fecal transplants for autism deliver success in clinical trials
6 hours ago
- #Autism Research
- #Fecal Transplants
- #Gut Microbiome
- Research links gut microbiome diversity to autism symptom reduction via fecal transplants.
- 30-50% of autistic individuals experience serious gastrointestinal issues like constipation and diarrhea.
- A 2019 study found fecal microbiota transplants improved autism symptoms by 24% after eight weeks, with a 45% reduction after two years.
- Two years post-treatment, 44% of participants fell below the mild autism threshold, down from 83% rated severe initially.
- Phase 2 trials for Microbiota Transplant Therapy (MTT) showed significant improvements in autism symptoms and gastrointestinal health.
- Researchers are seeking funding for Phase 3 trials to pursue FDA approval for the therapy.